Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Zevalin™: Treatment of non-Hodgkin's lymphoma
T. E. Witzig
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Zevalin™: Treatment of non-Hodgkin's lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
ibritumomab tiuxetan
100%
Non-Hodgkin's Lymphoma
57%
Yttrium
31%
Indium-111
29%
Pentetic Acid
13%
Chelating Agents
11%
Rituximab
10%
B-Cell Lymphoma
10%
Therapeutics
9%
Anti-Idiotypic Antibodies
8%
Outpatients
7%
Clinical Trials
6%
Quality of Life
6%
Antibodies
5%
Neoplasms
3%